ADMA Biologics (ADMA) announced it has repaid $30M from its original $62.5M senior secured term loan facility with Ares Capital. Following the partial paydown, ADMA has further reduced its total gross debt to $75M, comprised of its $42.5M revolving credit facility and $32.5M now outstanding under its term loan credit facility. The partial paydown was funded by utilizing cash on hand.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADMA: